161 filings
Page 2 of 9
8-K
u4vb88zu
1 Aug 23
Guardant resolves pending litigation with Illumina and enters into new agreement to advance long-term commercial partnership and cancer research
4:15pm
8-K
w8790qw
20 Jun 23
Submission of Matters to a Vote of Security Holders
4:08pm
8-K
tl69o6 fip
25 May 23
Other Events
4:05pm
424B5
rloy2c7gl
23 May 23
Prospectus supplement for primary offering
9:50pm
424B5
pxh5paqjx 6jzpzo
22 May 23
Prospectus supplement for primary offering
5:05pm
S-3ASR
ia3i65kjmf7wr
22 May 23
Automatic shelf registration
4:11pm
8-K
uks0l9jzk20he2j wj
9 May 23
Guardant Health Reports First Quarter 2023 Financial Results
4:13pm
8-K
j9b 19ixz
9 May 23
Guardant Health presents additional information from ECLIPSE study at 2023 Digestive Disease Week on the performance of Shield™ blood test
10:23am
8-K
4lh2u 4adx0b
8 May 23
Guardant Health Announces Additions to Leadership Team
4:29pm
ARS
xjdgsm zioh
27 Apr 23
Annual report to shareholders
4:24pm
DEFA14A
zv0p4y
27 Apr 23
Additional proxy soliciting materials
4:19pm
8-K
i8ony7ot2 ighjogofol
10 Apr 23
Changes in Registrant's Certifying Accountant
4:58pm
8-K
hbmwghw3aak 23c
10 Mar 23
Regulation FD Disclosure
9:05pm
S-8
vwk w88f49dd1
2 Mar 23
Registration of securities for employees
5:12pm
8-K
3q6 tq5jda99duko954
27 Feb 23
Musa Tariq joins Guardant Health board of directors
4:10pm
8-K
pvcpv8 mgqonoyp4
23 Feb 23
Guardant Health Reports Fourth Quarter and Full Year 2022 Financial Results and Provides 2023 Outlook
4:12pm
8-K
riobk
9 Jan 23
Guardant Health Announces Preliminary Fourth Quarter and Full Year 2022 Results
8:08am